Abstract
Estee Lauder will report fiscal fourth-quarter results on August 19, 2026 Pre-MKt; this preview outlines consensus projections for revenue, margins, net profit and adjusted EPS alongside business mix trends and the balance of institutional views between bullish and bearish camps.
Market Forecast
Consensus points to fiscal Q4 revenue of 3.54 billion US dollars, adjusted EPS of 0.32, and EBIT of 231.00 million US dollars, implying year-over-year changes of 4.29% for revenue, 267.76% for EPS, and 105.96% for EBIT; the modeled mix suggests a stable to modestly improving gross margin and a recovering net margin on lower promotions and normalized inventory. The business outlook emphasizes continued recovery in prestige beauty demand with a tilt toward skincare and selective fragrance strength; the most promising segment is skincare at 1.86 billion US dollars with improving trends versus last year.
Last Quarter Review
Estee Lauder’s prior quarter delivered revenue of 3.71 billion US dollars, a gross margin of 76.40%, GAAP net profit attributable to shareholders of 89.00 million US dollars with a net margin of 2.40%, and adjusted EPS of 0.91, each advancing year over year by 4.56% for revenue and 40.00% for EPS while net profit rose sequentially but with a quarter-on-quarter decline of 45.06% flagged in net profit growth. A notable highlight was EBIT of 557.00 million US dollars that exceeded the prior consensus by 149.25 million US dollars; within the business mix, skincare generated 1.86 billion US dollars, makeup 1.07 billion US dollars, fragrance 0.63 billion US dollars, hair care 0.13 billion US dollars, and other 0.03 billion US dollars.
Current Quarter Outlook
Main business trajectory
Management and market indicators suggest a sequential deceleration from the seasonally strong third quarter to the fiscal fourth quarter, yet the setup supports year-over-year growth. At projected revenue of 3.54 billion US dollars and EPS of 0.32, the model implies continued leverage from cost controls and reduced inventory charges. Gross margin resilience seen last quarter provides a cushion against currency and input-cost fluctuations, helping defend profitability even as promotional intensity normalizes in certain channels. Channel inventory health is a focal variable; cleaner partner inventories compared with last year are expected to support steadier orders and less volatility in shipments.
Most promising business
Skincare remains the key growth engine with an estimated 1.86 billion US dollars revenue contribution last quarter and signs of recovering travel retail throughput. The category benefits from flagship franchises and innovations with mix skew toward higher-margin products that aid gross margin stability. While growth is not uniform across regions, the combination of re-accelerating travel corridors, improving replenishment cycles, and ongoing product news positions skincare for relative outperformance. Continued execution on brand elevation and targeted marketing should help defend share without excessive discounting.
Stock price drivers this quarter
The primary swing factors are travel retail sell-through, China consumer demand, and the cadence of margin recovery. If traffic in key tourist hubs and airport channels sustains, revenue can track or exceed the 4.29% growth outlook with incremental operating leverage. China remains a two-sided risk where improving channel inventories may be offset by uneven consumer sentiment; order patterns from local partners into quarter-end will be closely parsed. On margins, investors will monitor whether gross margin holds close to the recent 76.40% level and if operating expenses scale in line with revenue; any confirmation of a durable net margin lift from the prior quarter’s 2.40% would be taken as validation of the recovery path.
Analyst Opinions
Across recent institutional commentary, the balance of opinion skews bullish, with positive calls citing cleaner inventories, early signs of travel retail stabilization, and operating margin recovery; bearish views tend to focus on China volatility and competitive intensity in prestige beauty. On the bullish side, multiple large-cap consumer analysts emphasize that the projected 267.76% year-over-year EPS increase in the fourth quarter, albeit off a low base, demonstrates the operating leverage embedded in Estee Lauder’s model as one-off headwinds fade. The improvement in EBIT toward 231.00 million US dollars alongside mid-single-digit revenue growth is framed as evidence that prior cost actions are flowing through. Bullish commentary also highlights that skincare’s scale and margin structure provide a favorable backdrop for mix-led expansion if innovation and hero franchises maintain momentum. Overall, the majority view anticipates an in-line to modest beat on revenue and EPS relative to current projections, with guidance color on travel retail and China as the key stock catalysts heading into the next fiscal year.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments